Table 2 Mean (sd) utility measures by presence of diabetes-related complications at baseline
% of study population | Utilities | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
Dolan (EQ-5D) | Shaw (EQ-5D) | Brazier SF-6D (SF12) | Brazier SF-6D (SF36) | Lundberg (SF-12) | Lawrence (SF12-MEPS) | Franks (SF12-MEPS) | Franks (SF12) | Fryback (SF36v1) | ||
All patients | 100% (n = 975) | 0.801 (0.206) | 0.848 (0.144) | 0.780 (0.131) | .746 (0.138) | 0.801 (0.103) | 0.728 (0.182) | .725 (0.189) | 0.744 (0.186) | 0.678 (0.079) |
MEDICAL CONDITION | ||||||||||
Stroke and/or TIA | Y 10.5% | .708 (0.259) | .783 (0.174) | .744 (0.141) | .700 (0.142) | .762 (0.112) | .659 (0.192) | .650 (0.207) | .666 (0.211) | .648 (0.082) |
N | .812 (0.196) | .856 (0.138) | .784 (0.129) | .751 (0.136) | .804 (0.102) | .736 (0.179) | .734 (0.185) | .754 (0.181) | .682 (0.078) | |
Peripheral Revascularization and/or Amputation | Y 5.4% | .722 (0.236) | .793 (0.159) | .730 (0.149) | .698 (0.146) | .751 (0.116) | .646 (0.207) | .633 (0.232) | .643 (0.250) | .638 (0.078) |
N | .805 (0.204) | .851 (0.143) | .782 (0.129) | .749 (0.137) | .803 (0.102) | .733 (0.179) | .730 (0.185) | .750 (0.180) | .681 (0.079) | |
Hospital admin for unstable Angina | Y 12.6% | .741 (0.242) | .805 (0.165) | .739 (0.148) | .703 (0.146) | .768 (0.116) | .661 (0.198) | .654 (0.214) | .678 (0.222) | .655 (0.083) |
N | .809 (0.199) | .854 (0.140) | .785 (0.127) | .752 (0.137) | .804 (0.101) | .737 (0.177) | .735 (0.184) | .754 (0.179) | .682 (0.078) | |
Myocardial Infarction | Y 18.8% | .767 (0.223) | .826 (0.152) | .764 (0.136) | .732 (0.138) | .778 (0.105) | .695 (0.182) | .692 (0.195) | .715 (0.200) | .665 (0.078) |
N | .808 (0.202) | .853 (0.142) | .783 (0.130) | .749 (0.138) | .805 (0.103) | .736 (0.181) | .732 (0.188) | .751 (0.182) | .682 (0.079) | |
Coronary artery bypass graft | Y 18.6% | .788 (0.211) | .839 (0.146) | .769 (0.136) | .736 (0.140) | .788 (0.107) | .710 (0.185) | .706 (0.198) | .727 (0.205) | .673 (0.082) |
N | .804 (0.205) | .850 (0.144) | .782 (0.130) | .748 (0.137) | .803 (0.102) | .732 (0.181) | .729 (0.187) | .748 (0.182) | .680 (0.079) | |
Currently treated Hypertension | Y 64.7% | .789 (0.209) | .839 (0.145) | .769 (0.132) | .735 (0.137) | .794 (0.102) | .710 (0.181) | .707 (0.190) | .728 (0.189) | .670 (0.078) |
N | .823 (0.199) | .865 (0.141) | .798 (0.127) | .767 (0.138) | .814 (0.103) | .763 (0.178) | .759 (0.184) | .775 (0.177) | .694 (0.080) | |
Diabetic Eye Disease incl. Blindness in either eye | Y 7.6% | .801 (0.177) | .848 (0.126) | .769 (0.131) | .732 (0.142) | .779 (0.105) | .697 (0.190) | .690 (0.202) | .710 (0.199) | .669 (0.073) |
N | .801 (0.208) | .848 (0.145) | .780 (0.131) | .747 (0.138) | .801 (0.103) | .731 (0.181) | .728 (0.188) | .747 (0.185) | .679 (0.080) | |
Patients without above conditions at baseline | 21.5% | .843 (0.186) | .877 (0.135) | .802 (0.125) | .771 (0.137) | .824 (0.098) | .778 (0.174) | .774 (0.177) | .788 (0.165) | .701 (0.079) |
Duration of Diabetes | >= 5 yrs 47.3% | .808 (0.208) | .853 (0.146) | .782 (0.133) | .750 (0.141) | .796 (0.105) | .726 (0.185) | .722 (0.193) | .740 (0.191) | .678 (0.082) |
6+ yrs 52.7% | .793 (0.205) | .843 (0.142) | .777 (0.129) | .743 (0.135) | .802 (0.102) | .730 (0.179) | .727 (0.186) | .748 (0.182) | .679 (0.077) | |